Alizyme to start Phase II with ATL-2502

Alizyme (LSE:AZM) said it is starting a 40-patient, U.K. Phase II trial with ATL-2502 prednisolone metasulphobenzoate in combination with COLAL, AZM's colonic drug delivery system, for the treatment o...